Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Neutral

Debt to Equity Rating

Buy

Price to Earnings Rating

Sell

Analyst Rating

Buy

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Strong Buy

Wall Street Data Solutions Rating

Buy

A

Pacira BioSciences, Inc. Common Stock (PCRX)

Pharmaceutical Preparations

https://www.pacira.com

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has launched EXPAREL which utilizes DepoFoam, a product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time.

5401 WEST KENNEDY BOULEVARD, SUITE 890
TAMPA, FL

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/03/2011

Market Cap

601,956,045

Shares Outstanding

46,440,000

Weighted SO

46,437,704

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

PAHC --.--%

RDY --.--%

COLL --.--%

SSIC --.--%

PBH --.--%

HCM --.--%

IXHL --.--%

EGRX --.--%

ANIP --.--%

Beta

0.8810

Last Div

0.0000

Range

11.16-38.23

Chg

-0.3000

Avg Vol

1260316

Mkt Cap

601956045

Exch

NASDAQ

Country

US

Phone

813 553 6680

DCF Diff

-34.6716

DCF

63.1316

Div Yield

0.0000

P/S

0.8720

EV Multiple

5.7814

P/FV

0.6853

Div Yield %

0.0000

P/E

9.4754

PEG

1.4295

Payout

0.0000

Current Ratio

6.8207

Quick Ratio

5.7048

Cash Ratio

2.6654

DSO

55.5074

DIO

170.0011

Op Cycle

225.5086

DPO

30.7829

CCC

194.7257

Gross Margin

0.6783

Op Margin

0.1416

Pretax Margin

0.1457

Net Margin

0.0921

Eff Tax Rate

0.3675

ROA

0.0386

ROE

0.0732

ROCE

0.0629

NI/EBT

0.6325

EBT/EBIT

1.0283

EBIT/Rev

0.1416

Debt Ratio

0.3634

D/E

0.6806

LT Debt/Cap

0.4013

Total Debt/Cap

0.4050

Int Coverage

15.4907

CF/Debt

0.3248

Equity Multi

1.8729

Rec Turnover

6.5757

Pay Turnover

11.8572

Inv Turnover

2.1470

FA Turnover

3.0665

Asset Turnover

0.4192

OCF/Share

4.2093

FCF/Share

4.0010

Cash/Share

8.7544

OCF/Sales

0.2816

FCF/OCF

0.9505

CF Coverage

0.3248

ST Coverage

21.2437

CapEx Coverage

20.2078

Div&CapEx Cov

20.2078

P/BV

0.6853

P/B

0.6853

P/S

0.8720

P/E

9.4754

P/FCF

3.2584

P/OCF

3.1003

P/CF

3.1003

PEG

1.4295

P/S

0.8720

EV Multiple

5.7814

P/FV

0.6853

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. May 27, 01:54 Grabar Law Office Investigates Claims on Behalf of Shareholders of DoubleVerify Holdings, Inc. (NYSE: DV); NAPCO Securities Technologies, Inc. (NASDAQ: NSSC); Pacira Biosciences, Inc. (NASDAQ: PCRX); and Treace Medical Concepts, Inc. (NASDAQ: TMCI) GlobeNewswire Inc. Mar 14, 00:04 PCRX DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 14 Deadline in Securities Class Action – PCRX GlobeNewswire Inc. Mar 05, 02:28 PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. - PCRX GlobeNewswire Inc. Feb 26, 03:08 PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. - PCRX GlobeNewswire Inc. Feb 24, 23:30 ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PCRX GlobeNewswire Inc. Feb 20, 03:05 PACIRA BIOSCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. - PCRX GlobeNewswire Inc. Feb 18, 23:27 PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. - PCRX GlobeNewswire Inc. Feb 13, 03:37 PACIRA BIOSCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. - PCRX GlobeNewswire Inc. Feb 12, 03:35 ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PCRX GlobeNewswire Inc. Feb 12, 03:29 PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. – PCRX GlobeNewswire Inc. Feb 08, 16:31 ROSEN, LEADING INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PCRX GlobeNewswire Inc. Feb 06, 03:13 PACIRA BIOSCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. - PCRX GlobeNewswire Inc. Feb 05, 03:41 PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. - PCRX GlobeNewswire Inc. Feb 02, 21:00 PCRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Pacira BioSciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire Inc. Jan 31, 21:52 PCRX Stockholders Should Contact Shareholder Rights Firm Robbins for Information About the Class Action Against Pacira BioSciences, Inc. GlobeNewswire Inc. Jan 30, 03:38 PACIRA BIOSCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. - PCRX GlobeNewswire Inc. Jan 29, 03:51 PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. - PCRX GlobeNewswire Inc. Jan 23, 03:49 PACIRA BIOSCIENCES SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. - PCRX GlobeNewswire Inc. Jan 22, 03:52 PACIRA BIOSCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Pacira BioSciences, Inc. - PCRX GlobeNewswire Inc. Jan 17, 22:29 PCRX Investor Alert: Shareholder Rights Law Firm Robbins LLP Reminds Shareholders of the Class Action Lawsuit Against Pacira BioSciences, Inc.

Revenue Product Segmentation